Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915837 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
A Phase 1 study of Diabetic Macular Edema, sponsored by SurModics.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 4
- Study locations
NCT00915837: Completed Phase 1 study of Diabetic Macular Edema, sponsored by SurModics.
NCT00915837 is a Phase 1 study of Diabetic Macular Edema that has completed, run by SurModics. The registered enrollment target is 31 participants, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00915837, a Phase 1 study of Diabetic Macular Edema, has completed, sponsored by SurModics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 4
- Study locations
Study Summary
This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.
Conditions Studied
Interventions
- DRUG triamcinolone acetonide
Study Locations (4)
Arizona
- Retinal Consultants of Arizona - Phoenix
California
- California Retina Consultants - Santa Barbara
Michigan
- Kresege Eye Institute - Detroit
Minnesota
- VitreoRetinal Surgery, PA - Edina
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2005-06 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
What the finished NCT00915837 record still lists
NCT00915837 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetic Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which triamcinolone acetonide is the first listed.
NCT00915837 reports a single indexed study location in Arizona, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT00915837 about?
NCT00915837 is a clinical study titled "Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema". This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.
What is the current status of trial NCT00915837?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2005-06. Estimated completion is 2009-05.
What conditions does trial NCT00915837 study?
This clinical trial studies the following conditions: Diabetic Macular Edema.
What interventions are being tested in trial NCT00915837?
The interventions under investigation include: triamcinolone acetonide (DRUG).
Who is sponsoring clinical trial NCT00915837?
This trial is sponsored by SurModics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00915837 being conducted?
This trial has 4 study locations across Arizona, California, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Macular Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00915837's enrollment target sits among peer trials
31 44th of 63 higher than 20 of 63 other Diabetic Macular Edema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Macular Edema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)
RECRUITING · Phase 1
-
EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
RECRUITING · Phase 1
-
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
RECRUITING · Phase 1
-
Kamuvudine-9 (K9) in Diabetic Macular Edema
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia